{"id":1247,"date":"2017-04-10T11:17:33","date_gmt":"2017-04-10T10:17:33","guid":{"rendered":"https:\/\/colox.ch\/?p=1247"},"modified":"2018-04-18T15:56:31","modified_gmt":"2018-04-18T14:56:31","slug":"le-cancer-du-colon","status":"publish","type":"post","link":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/","title":{"rendered":"Le cancer du c\u00f4lon"},"content":{"rendered":"<p>Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe<sup><small>1<\/small><\/sup>. Le nombre de cas devrait encore augmenter ces vingt prochaines ann\u00e9es en raison du vieillissement de la population. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.<\/p>\n<p>La plupart des cancers du c\u00f4lon se d\u00e9veloppent lentement pendant plusieurs ann\u00e9es. Il s\u2019agit souvent au d\u00e9part de l\u00e9sions pr\u00e9curseurs b\u00e9nignes appel\u00e9es polypes ad\u00e9nomateux. Avec le temps ces l\u00e9sions b\u00e9nignes du c\u00f4lon peuvent se transformer en cancer. Les tumeurs \u00e0 des stades pr\u00e9coces (localis\u00e9es qui se limitent \u00e0 la paroi du c\u00f4lon) peuvent \u00eatre \u00e9limin\u00e9es par une op\u00e9ration chirurgicale. Plus de 90 % des patients diagnostiqu\u00e9s \u00e0 un stade pr\u00e9coce peuvent \u00eatre d\u00e9finitivement gu\u00e9ris. Par contre dans des stades plus avanc\u00e9s, le cancer se propage localement et le taux de survie descend \u00e0 70 %. Par la suite, si le cancer devient m\u00e9tastatique, le taux de survie chute \u00e0 10 %<sup><small>2<\/small><\/sup>.<\/p>\n<p>La Commission Europ\u00e9enne<sup><small>3<\/small><\/sup>\u00a0et la Ligue suisse contre le cancer<sup><small>4<\/small><\/sup>\u00a0recommandent le d\u00e9pistage r\u00e9gulier de la population avec un risque moyen, d\u00e8s l\u2019\u00e2ge de 50 ans comme une mesure essentielle pour une d\u00e9tection et une intervention pr\u00e9coce du cancer du c\u00f4lon. Actuellement, les outils de d\u00e9pistage recommand\u00e9s en Europe comprennent notamment la coloscopie et les tests de recherche de sang occulte dans les selles.<\/p>\n<p>Malheureusement, en raison du caract\u00e8re peu agr\u00e9able de ces tests et de la crainte g\u00e9n\u00e9r\u00e9e par des proc\u00e9dures invasives, la compliance au d\u00e9pistage est insuffisante. Cette faible compliance engendre une incidence et un taux de mortalit\u00e9 inutilement \u00e9lev\u00e9s et pourtant \u00e9vitable du cancer du c\u00f4lon.<\/p>\n<p>Novigenix s\u2019engage \u00e0 aider les patients et la communaut\u00e9 m\u00e9dicale en mettant \u00e0 leur disposition un <a href=\"https:\/\/colox.ch\/colox\/\">test sanguin<\/a> innovant et efficace visant \u00e0 r\u00e9duire les taux d\u2019incidence et de mortalit\u00e9 du cancer colorectal par une d\u00e9tection pr\u00e9coce de la maladie.<\/p>\n<h4>R\u00e9f\u00e9rences:<\/h4>\n<p><small>1)\u00a0<a href=\"http:\/\/globocan.iarc.fr\/Default.aspx\" target=\"_blank\" rel=\"noopener\">World Health Organization, International Agency for Research on Cancer, GLOBOCAN2012: Estimated Cancer Incidence, Mortality, and Prevelance Worldwide in 2012<\/a>\u00a0<\/small><br \/>\n<small>2)\u00a0<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2796096\/\" target=\"_blank\" rel=\"noopener\">Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors. Fatima A. Haggar et al.\u00a0 Clin C\u00f4lon Surg. Nov 2009 22(4): 191-197<\/a><\/small><br \/>\n<small>3)\u00a0<a href=\"http:\/\/ec.europa.eu\/health\/major_chronic_diseases\/diseases\/cancer\/index_en.htm\" target=\"_blank\" rel=\"noopener\">European guidelines for quality assurance in colorectal cancer screening and diagnosis\u00a0<\/a><\/small><br \/>\n<small>4)\u00a0<a href=\"http:\/\/www.liguecancer.ch\/\" target=\"_blank\" rel=\"noopener\">Ligue suisse contre le cancer<\/a>\u00a0<\/small><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe1. Le nombre de cas devrait encore augmenter ces vingt prochaines ann\u00e9es en raison du vieillissement de la population. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63],"tags":[30,31,32],"class_list":["post-1247","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-generalites-cancer-du-colon","tag-cancer","tag-colon","tag-mortalite"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Le cancer du c\u00f4lon - Colox<\/title>\n<meta name=\"description\" content=\"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le cancer du c\u00f4lon - Colox\" \/>\n<meta property=\"og:description\" content=\"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\" \/>\n<meta property=\"og:site_name\" content=\"Colox\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/mymiddlelife\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-10T10:17:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-18T14:56:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"733\" \/>\n\t<meta property=\"og:image:height\" content=\"445\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Novigenix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Novigenix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\"},\"author\":{\"name\":\"Novigenix\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/b62de2e3f97aea1ffe3303259cbbb20a\"},\"headline\":\"Le cancer du c\u00f4lon\",\"datePublished\":\"2017-04-10T10:17:33+00:00\",\"dateModified\":\"2018-04-18T14:56:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\"},\"wordCount\":430,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/colox.ch\/de\/#organization\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg\",\"keywords\":[\"cancer\",\"c\u00f4lon\",\"mortalit\u00e9\"],\"articleSection\":[\"G\u00e9n\u00e9ralit\u00e9s cancer du c\u00f4lon\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\",\"url\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\",\"name\":\"Le cancer du c\u00f4lon - Colox\",\"isPartOf\":{\"@id\":\"https:\/\/colox.ch\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg\",\"datePublished\":\"2017-04-10T10:17:33+00:00\",\"dateModified\":\"2018-04-18T14:56:31+00:00\",\"description\":\"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.\",\"breadcrumb\":{\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage\",\"url\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg\",\"contentUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg\",\"width\":733,\"height\":445},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/colox.ch\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le cancer du c\u00f4lon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/colox.ch\/de\/#website\",\"url\":\"https:\/\/colox.ch\/de\/\",\"name\":\"Colox\",\"description\":\"The new generation blood test\",\"publisher\":{\"@id\":\"https:\/\/colox.ch\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/colox.ch\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/colox.ch\/de\/#organization\",\"name\":\"Novigenix SA\",\"url\":\"https:\/\/colox.ch\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png\",\"contentUrl\":\"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png\",\"width\":700,\"height\":297,\"caption\":\"Novigenix SA\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/b62de2e3f97aea1ffe3303259cbbb20a\",\"name\":\"Novigenix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/09\/Novigenix_avatar-96x96.png\",\"contentUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/09\/Novigenix_avatar-96x96.png\",\"caption\":\"Novigenix\"},\"description\":\"Novigenix is an innovative Swiss molecular diagnostics company specializing in new generation blood tests for early detection of cancer. Colox\u00ae, our lead product is a proven molecular blood test designed to significantly reduce mortality from colorectal cancer through early detection and follow-up colonoscopy. Novigenix\u2019s technology is based on a new generation of predictive gene expression profiles of circulating blood cells and concentration profile of tumor-derived protein markers in combination with state-of-the-art mathematical analytical models. Our predictive molecular signatures of biomarkers provide new and accurate solutions for the early detection of cancer.\",\"sameAs\":[\"https:\/\/colox.ch\",\"https:\/\/www.facebook.com\/mymiddlelife\/\"],\"url\":\"https:\/\/colox.ch\/fr\/author\/novigenix\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le cancer du c\u00f4lon - Colox","description":"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/","og_locale":"fr_FR","og_type":"article","og_title":"Le cancer du c\u00f4lon - Colox","og_description":"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.","og_url":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/","og_site_name":"Colox","article_author":"https:\/\/www.facebook.com\/mymiddlelife\/","article_published_time":"2017-04-10T10:17:33+00:00","article_modified_time":"2018-04-18T14:56:31+00:00","og_image":[{"width":733,"height":445,"url":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg","type":"image\/jpeg"}],"author":"Novigenix","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Novigenix","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#article","isPartOf":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/"},"author":{"name":"Novigenix","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/b62de2e3f97aea1ffe3303259cbbb20a"},"headline":"Le cancer du c\u00f4lon","datePublished":"2017-04-10T10:17:33+00:00","dateModified":"2018-04-18T14:56:31+00:00","mainEntityOfPage":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/"},"wordCount":430,"commentCount":0,"publisher":{"@id":"https:\/\/colox.ch\/de\/#organization"},"image":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage"},"thumbnailUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg","keywords":["cancer","c\u00f4lon","mortalit\u00e9"],"articleSection":["G\u00e9n\u00e9ralit\u00e9s cancer du c\u00f4lon"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/","url":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/","name":"Le cancer du c\u00f4lon - Colox","isPartOf":{"@id":"https:\/\/colox.ch\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage"},"image":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage"},"thumbnailUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg","datePublished":"2017-04-10T10:17:33+00:00","dateModified":"2018-04-18T14:56:31+00:00","description":"Le cancer du c\u00f4lon repr\u00e9sente la deuxi\u00e8me cause de mortalit\u00e9 par cancer chez les hommes et les femmes en Europe. Mais s\u2019il est diagnostiqu\u00e9 suffisamment t\u00f4t, le cancer du c\u00f4lon a un taux \u00e9lev\u00e9 de gu\u00e9rison et peut \u00eatre pr\u00e9venu par l\u2019ablation des polypes ad\u00e9nomateux.","breadcrumb":{"@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/colox.ch\/fr\/le-cancer-du-colon\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#primaryimage","url":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg","contentUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/photo2.jpg","width":733,"height":445},{"@type":"BreadcrumbList","@id":"https:\/\/colox.ch\/fr\/le-cancer-du-colon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/colox.ch\/"},{"@type":"ListItem","position":2,"name":"Le cancer du c\u00f4lon"}]},{"@type":"WebSite","@id":"https:\/\/colox.ch\/de\/#website","url":"https:\/\/colox.ch\/de\/","name":"Colox","description":"The new generation blood test","publisher":{"@id":"https:\/\/colox.ch\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/colox.ch\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/colox.ch\/de\/#organization","name":"Novigenix SA","url":"https:\/\/colox.ch\/de\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/","url":"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png","contentUrl":"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png","width":700,"height":297,"caption":"Novigenix SA"},"image":{"@id":"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/b62de2e3f97aea1ffe3303259cbbb20a","name":"Novigenix","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/image\/","url":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/09\/Novigenix_avatar-96x96.png","contentUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/09\/Novigenix_avatar-96x96.png","caption":"Novigenix"},"description":"Novigenix is an innovative Swiss molecular diagnostics company specializing in new generation blood tests for early detection of cancer. Colox\u00ae, our lead product is a proven molecular blood test designed to significantly reduce mortality from colorectal cancer through early detection and follow-up colonoscopy. Novigenix\u2019s technology is based on a new generation of predictive gene expression profiles of circulating blood cells and concentration profile of tumor-derived protein markers in combination with state-of-the-art mathematical analytical models. Our predictive molecular signatures of biomarkers provide new and accurate solutions for the early detection of cancer.","sameAs":["https:\/\/colox.ch","https:\/\/www.facebook.com\/mymiddlelife\/"],"url":"https:\/\/colox.ch\/fr\/author\/novigenix\/"}]}},"_links":{"self":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts\/1247"}],"collection":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/comments?post=1247"}],"version-history":[{"count":0,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts\/1247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/media\/3155"}],"wp:attachment":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/media?parent=1247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/categories?post=1247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/tags?post=1247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}